Literature DB >> 22010162

Genetic variants in the apolipoprotein(a) gene and coronary heart disease.

Yonghong Li1, May M Luke, Dov Shiffman, James J Devlin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22010162     DOI： 10.1161/CIRCGENETICS.111.959601

Source DB:  PubMed          Journal:  Circ Cardiovasc Genet        ISSN： 1942-3268


× No keyword cloud information.
  26 in total

Review 1.  Genetics of lipid traits and relationship to coronary artery disease.

Authors:  Tanya E Keenan; Daniel J Rader
Journal:  Curr Cardiol Rep       Date:  2013-09       Impact factor: 2.931

Review 2.  Update on lipoprotein(a) as a cardiovascular risk factor and mediator.

Authors:  Michael B Boffa; Marlys L Koschinsky
Journal:  Curr Atheroscler Rep       Date:  2013-10       Impact factor: 5.113

Review 3.  Targeting lipoprotein (a): an evolving therapeutic landscape.

Authors:  Lillian C Man; Erik Kelly; Danielle Duffy
Journal:  Curr Atheroscler Rep       Date:  2015-05       Impact factor: 5.113

4.  Relook at lipoprotein (A): independent risk factor of coronary artery disease in north Indian population.

Authors:  Jamal Yusuf; Neeraj Yadav; Saibal Mukhopadhyay; Abhishek Goyal; Vimal Mehta; Vijay Trehan; Sanjay Tyagi
Journal:  Indian Heart J       Date:  2014-04-21

Review 5.  Structure, function, and genetics of lipoprotein (a).

Authors:  Konrad Schmidt; Asma Noureen; Florian Kronenberg; Gerd Utermann
Journal:  J Lipid Res       Date:  2016-04-13       Impact factor: 5.922

6.  Determinants of binding of oxidized phospholipids on apolipoprotein (a) and lipoprotein (a).

Authors:  Gregor Leibundgut; Corey Scipione; Huiyong Yin; Matthias Schneider; Michael B Boffa; Simone Green; Xiaohong Yang; Edward Dennis; Joseph L Witztum; Marlys L Koschinsky; Sotirios Tsimikas
Journal:  J Lipid Res       Date:  2013-07-04       Impact factor: 5.922

7.  LPA Gene, Ethnicity, and Cardiovascular Events.

Authors:  Sang-Rok Lee; Anand Prasad; Yun-Seok Choi; Chao Xing; Paul Clopton; Joseph L Witztum; Sotirios Tsimikas
Journal:  Circulation       Date:  2016-11-09       Impact factor: 29.690

8.  Mipomersen, an antisense oligonucleotide to apolipoprotein B-100, reduces lipoprotein(a) in various populations with hypercholesterolemia: results of 4 phase III trials.

Authors:  Raul D Santos; Frederick J Raal; Alberico L Catapano; Joseph L Witztum; Elisabeth Steinhagen-Thiessen; Sotirios Tsimikas
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-01-22       Impact factor: 8.311

9.  Lipoprotein(a) and cardiovascular disease in diabetic patients.

Authors:  Qibin Qi; Lu Qi
Journal:  Clin Lipidol       Date:  2012-08

Review 10.  Lipoprotein(a): novel target and emergence of novel therapies to lower cardiovascular disease risk.

Authors:  Sotirios Tsimikas
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2016-04       Impact factor: 3.243
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.